# METHYLPREDNISOLONE SODIUM SUCCINATE
> **ANDA040662** · Abbreviated New Drug Application (Generic) · Sponsor: BEDFORD LABS · Approved 2007-02-21
## Drug
- **FDA Application Number:** ANDA040662
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHYLPREDNISOLONE SODIUM SUCCINATE
- **Generic name:** Methylprednisolone Sodium Succinate
- **Active ingredients:** METHYLPREDNISOLONE SODIUM SUCCINATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** BEDFORD LABS
- **First approval:** 2007-02-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040662)
---
*AI Analytics · CC0 1.0*